Anaphylactic reaction to gonadotropin-releasing hormone analogues: a pediatric case report. 2018

Franco Ricci, and Maurizio de Martino, and Stefano Stagi
Department of Health Sciences Anna Meyer Children's University Hospital University of Florence Florence Italy.

Gonadotropin-releasing hormone (GnRH) analogues represent the gold standard treatment for precocious puberty. Allergic-type reactions in children due to this type of treatment are very rare. However, caregivers should be aware of the potential GnRH analogue systemic reactions.

UI MeSH Term Description Entries

Related Publications

Franco Ricci, and Maurizio de Martino, and Stefano Stagi
March 1993, The New England journal of medicine,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
March 2011, The American journal of the medical sciences,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
September 1987, Fertility and sterility,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
March 1993, Drug and therapeutics bulletin,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
April 1990, Annals of medicine,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
August 1991, The New England journal of medicine,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
January 1991, The New England journal of medicine,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
June 2023, The Cochrane database of systematic reviews,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
October 2014, AANA journal,
Franco Ricci, and Maurizio de Martino, and Stefano Stagi
March 1995, European journal of pediatrics,
Copied contents to your clipboard!